RE: Must be substance here14 Apr 2020 15:13
From RNS:
"As announced on 28 January 2020 and 18 March 2020 Motif BioSciences Inc.
("Motif Inc"), the company's wholly owned subsidiary, ceased all operations
and engaged Tamarack Associates to facilitate the sale of iclaprim and other
assets of Motif Inc. It remains the case that in spite of a comprehensive
outreach programme, no transaction is currently pending for the sale of Motif
Inc.'s assets ..."so they still own everything imo.